BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8371494)

  • 1. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
    Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae].
    Sugita R; Deguchi K; Kimura S; Harada S; Fujimaki Y; Watanabe H; Naito M; Nomura T; Tanaka M; Komatsu N; Shimizu K; Yoshida Y; Okano K
    Jpn J Antibiot; 1996 Apr; 49(4):386-98. PubMed ID: 8786629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains].
    Sugita R; Deguchi K; Fujimaki Y; Harada S; Shimizu K; Kimura S; Watanabe H; Komatsu N; Okano K; Naito M; Nomura T; Tanaka M; Yoshida Y; Tanaka H; Iwai N; Nakamura H
    Jpn J Antibiot; 1997 Aug; 50(8):727-37. PubMed ID: 9339399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Takajo N; Okabayashi S
    Jpn J Antibiot; 1992 Dec; 45(12):1700-35. PubMed ID: 1289589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic, bacteriological and clinical studies on S-1108 in children].
    Tajima T; Kondo Y; Negishi S; Nishimura S; Yoshida A; Hagiwara N; Niimi R; Esaki E; Kaneko S; Abe T
    Jpn J Antibiot; 1993 Nov; 46(11):953-8. PubMed ID: 8309071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cefdinir 5% fine granules in pediatrics].
    Iwai N; Nakamura H; Taneda Y; Miyazu M; Kasai K; Watanabe Y
    Jpn J Antibiot; 1991 Oct; 44(10):1096-118. PubMed ID: 1762167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
    Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K
    Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
    Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
    Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic, bacteriological, and clinical studies on SY5555 in children].
    Tajima T; Kobayashi M; Hata M; Negishi S; Kubota K; Iitsuka T; Hagiwara N; Kudou S; Nakayama T; Abe T
    Jpn J Antibiot; 1995 Jan; 48(1):31-40. PubMed ID: 7699843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.